다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Vallon Pharmaceuticals Inc (VLON)
Vallon Pharmaceuticals Inc (VLON) 뉴스

VLON

Vallon Pharmaceuticals (VLON)

Vallon Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VLON

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/23	05:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/21	05:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/21	05:11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/17	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/17	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/15	05:46	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/15	05:44	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/13	21:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/11	06:24	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/11	05:53	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/10	05:31	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/04/01	22:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/03/29	05:45	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/03/29	05:42	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/02/03	06:25	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/02/03	06:23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/02/03	06:21	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/02/02	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/01/30	22:13	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/01/30	22:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/01/20	06:16	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/01/20	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/01/16	22:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2023/12/21	07:12	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2023/12/18	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2023/12/16	07:02	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2023/12/05	23:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2023/11/27	22:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2023/11/25	06:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2023/11/15	22:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:VLON

1 2 3 4 5 6 다음 >>

Ninepoint Alternative He...

Keelt Group Tf 6% Gn27 A...

Gamelancer Media

First Trust Tcw Securiti...

Spirax Sarco Engineering (PK)

Imagion Biosystems

Cyprus Tf 2,75% Fb34 Eur

Newday Fmi 25 S

HDAX Total Return CHF

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관